SlideShare a Scribd company logo
1
PROBLEM OF ANTIBIOTIC
RESISTANCE & RATIONAL USE
OF ANTIBIOTICS
SUHAIL K
Lecturer
Crescent college of pharmaceutical sciences
suhailk4@gmail.com
2
INTRODUCTION
Throughout history there has been a continual battle
between human beings and multitude of micro-organisms
that cause infection and disease.
ANTIBIOTICS:
Produced by micro organism, which selectively
suppress the growth of or kill other micro organisms at
very low concentrations.
3
PROBLEMS WITH USE OF AMAs
1. Toxicity:
Local irritancy
Systemic toxicity
2. Hypersensitivity reactions
3. Superinfection
4. Nutritional deficiencies
5. Masking of an infection
6. Drug resistance 4
Drug resistance occurs in :
Bacteria—Antibiotic Resistance
Endoparasites
Viruses—Resistance to antiviral drugs
Fungi
Cancer cells
5
In his 1945 Nobel Prize lecture, Fleming himself
warned of the danger of resistance –
“It is not difficult to make microbes resistant to
penicillin in the laboratory by exposing them to
concentrations not sufficient to kill them, and the same
thing has occasionally happened in the body……and by
exposing his microbes to non-lethal quantities of the
drug make them resistant.”
6
Why resistance is a concern:
•Resistant organisms lead to treatment failure
•Increased mortality
•Resistant bacteria may spread in Community
•Low level resistance can go undetected
•Added burden on healthcare costs
•Threatens to return to pre-antibiotic era
•Selection pressure
7
Antibiotic Resistance
The concentration of drug at the site of infection
must inhibit the organism and also remain below the
level that is toxic to human cells.
Defined as micro-organisms that are not inhibited by
usually achievable systemic concentration of an
antimicrobial agent with normal dosage schedule and /
or fall in the minimum inhibitory concentration (MIC)
range. 8
9
10
Antibiotic Resistance
Some microorganisms may ‘born’ resistant, some
‘achieve’ resistance by mutation or some have
resistance ‘thrust upon them’ by plasmids
Some are born great, some achieve greatness or
some have greatness thrust upon them.
11
Intrinsic Resistance
It occurs naturally.
1. Lack target :
• No cell wall; innately resistant to penicillin
2. Innate efflux pumps:
• Drug blocked from entering cell or ↑ export of drug
(does not achieve adequate internal concentration). Eg.
E. coli, P. aeruginosa
3. Drug inactivation:
• Cephalosporinase in Klebsiella
12
Acquired resistance
Mutations
• It refers to the change in DNA structure of the gene.
• Occurs at a frequency of one per ten million cells.
• Eg.Mycobacterium tuberculosis,Mycobacterium lepra
, MRSA.
• Often mutants have reduced susceptibility
13
Plasmids
• Extra chromosomal genetic elements can replicate
independently and freely in cytoplasm.
• Plasmids which carry genes resistant ( r-genes) are
called R plasmids.
• These r-genes can be readily transferred from one R-
plasmid to another plasmid or to chromosome.
• Much of the drug resistance encountered in clinical
practice is plasmid mediated
14
15
Biochemical mechanisms of antibiotic resistance
• Prevention of drug accumulation in the bacterium
• Modification/protection of the target site
• Use of alternative pathways for metabolic / growth
requirements
• By producing an enzyme that inactivates the
antibiotic
• Quorum sensing
16
Decreased permeability: Porin Loss
Antibiotics normally enter bacterial cells via porin
channels in the cell wall
New porin channels in the bacterial cell wall do not
allow antibiotics to enter the cells
17
18
19
Structurally modified antibiotic target site
Antibiotics normally bind to specific binding proteins
on the bacterial cell surface
Antibiotics are no longer able to bind to modified
binding proteins on the bacterial cell surface
20
Modification/Protection of the Target site
Target sites Resistant Antibiotics
Ribosomal point mutation
eg.: Tetracyclines,Macrolides, Clindamycin
Altered DNA gyrase. Eg: Fluoroquinolones
Modified penicillin binding proteins
(Strepto.pneumonia) Eg: Penicillins
Mutation in DNA dependant RNA polymerase
(M.tuberculosis) Eg: Rifampicin
21
Antibiotic inactivation
Inactivating enzymes target antibiotics
Enzymes bind to antibiotic molecules and destroy or
prevent binding to target sites
22
a)Inactivation of b-lactam antibiotics
•S. aureus, N. gonorrohoea, H.influenza, Produce
blactamase which cleaves -lactam ring
b)Inactivation of Chloramphenicol
• Inactivated by chloramphenicol acetyltransferase .
• Gram-ve (enzyme present constitutively hence higher
resistance) gram +ve bacteria (enzyme is inducible )
c)Inactivation of Aminoglycosides
• Inactivated by acetyl, phospho & adenylyl transferases
Present in gram +ve and gram –ve .
23
24
Use of alternative pathways for metabolic / growth
requirements
• Resistance can also occur by alternate pathway that
bypasses the reaction inhibited by the antibiotic.
• Sulfonamide resistance can occur from over
production of PABA
25
Quorum sensing
• Microbes communicate with each other and exchange
signaling chemicals (Autoinducers)
• These autoinducers allow bacterial population to
coordinate gene expression for virulence, conjugation,
apoptosis, mobility and Resistance.
• Single autoinducer from single microbe is incapable of
inducing any such change
• But when its colony reaches a critical density (quorum),
threshold of autoinduction is reached and gene
26
WHY INHIBIT QUORUM SENSING
Proved to be very potent method for bacterial virulence
inhibition.
Several QS inhibitors molecules has been synthesized
which include AHL, AIP, and AI-2 analogues
QS inhibitors have been synthesized and have been
isolated from several natural extracts such as garlic
extract.
27
Factors of
Antibiotic
Resistance
Drug
Related
Factors
Environ
mental
Factors
Prescriber
Related
Factors
Patient
Related
Factors
28
Environmental Factors
Huge populations and overcrowding
• Rapid spread by better transport facility
• Poor sanitation
• Increases community acquired resistance
• Ineffective infection control program
• Widespread use of antibiotics in animal husbandry
and agriculture and as medicated cleansing products
29
Drug Related Factors
• Over the counter availability of antimicrobials
• Counterfeit and substandard drug causing suboptimal
blood concentration
• Irrational fixed dose combination of antimicrobials
• Soaring use of antibiotics
30
Patient Related Factors
• Poor adherence of dosage Regimens
• Poverty
• Lack of sanitation concept
• Lack of education
• Self-medication
• Misconception
31
Prescriber Related Factors
• Inappropriate use of available drugs
• Increased empiric poly-antimicrobial use
• Over use of antimicrobials
• Inadequate dosing
• Lack of current knowledge and training
32
Strategy to Contain Resistance
• Develop new antibiotics
– Bypass the drug resistance
• Judicious use of the existing antibiotics:
– Containment of drug resistance
33
• Only 15 antibiotics of 167 under development had a
new mechanism of action with the potential to combat
of multidrug resistance.
• Lack of incentive for companies to develop
antibiotics.
34
35
Hope is not exhausted….yet
Phage therapy
• Use of the lytic enzymes found in mucus and saliva
• Agents that target type IIA topoisomerases
• Antimicrobial peptides (AMPs), lipopeptides (AMLPs)
target bacterial membranes, making it nearly impossible to
develop resistance (bacteria would have to totally change
their membrane composition).
36
Phage therapy
• Phage Therapy is the therapeutic use of lytic
bacteriophages to treat pathogenic bacteria infections
• Bacteriophages are viruses that invade bacterial cells and
disrupt bacterial metabolism.
• The success rate was 80–95%
• British studies also demonstrated significant efficacy of
phages against Escherichia coli, Acinetobacter sp,
Pseudomonas sp and Staphylococcus aureus.
37
Prevention and control
Antibiotic resistance is accelerated by the misuse and
overuse of antibiotics, as well as poor infection
prevention and control.
Steps can be taken at all levels of society to reduce the
impact and limit the spread of resistance.
38
39
Individuals
• Only use antibiotics when prescribed
• Never demand antibiotics if your health worker says
you don’t need them.
• Always follow your health worker’s advice when using
antibiotics.
• Never share or use leftover antibiotics.
40
• Prevent infections by regularly washing hands, preparing food
hygienically, avoiding close contact with sick people, practicing
safer sex, and keeping vaccinations up to date.
• Prepare food hygienically, following the WHO Five Keys to Safer
Food (keep clean, separate raw and cooked, cook thoroughly, keep
food at safe temperatures, use safe water and raw materials) and
choose foods that have been produced without the use of antibiotics
for growth promotion or disease prevention in healthy animals.
Poor Clinical Practice
Poor clinical practice that fail to incorporate the
pharmacological properties of antimicrobials amplify
the speed of development of drug resistance
41
Faulty Antibiotic Use
• Antimicrobials are over prescribed
• Available without prescription
• Clinician should first determine whether
antimicrobial therapy is warranted for a given
patient
42
Empirical Microbial Selection
• Is antimicrobial agents indicated on the basis of clinical
findings?
• Or is it prudent to wait until such clinical findings
become apparent?
•Can some simple bed side test done to confirm your
suspicion?
– Microscopy
– Gram staining
Have appropriate clinical specimens been obtained to
43
• What are the likely etiologic agents for the patient’s
illness?
• Is there clinical evidence (e.g. from clinical trials) that
antimicrobial therapy will confer clinical benefit for the
patient? (Evidence-based medicine)
44
Definitive Treatment
• Can a narrower spectrum agent be substituted for initial
empiric drug?
• Is one agent or combination of agents necessary?
• What are the
– optimum dose,
– route of administration and
– duration of therapy?
• What specific test to identify patients who will not respond
to treatment? 45
• What adjunctive measures can be undertaken to
eradicate infection?
– Vaccination
– Steroid
– Drainage of pus
– Amputation
– Removal of catheter
46
Microbiologist
Bacterial sensitivity test and find out the possible
causes of development
Physician
treatment
47
PHARMACOLOGIST
Advise the proper and adequate antibiotics with
balancing the economy of hospital
48
Role of Pharmacist in Combating Resistance:
• Promote awareness among the population, for ethical or
proper safe use of antibiotics.
• Must obtain accreditation and training for disbursement
of knowledge about antibiotic.
• Helping physicians with drug selection and deciding on
duration of therapy, designing and promotion of clinical
practice guidelines, implementation of antibiotic switch
programmes, and documentation of the effectiveness of
interventions.
49
• All hospitals should have an antibiotic pharmacist who
has the rights to interfere in the treatment which are
associated with antibiotics in the prescription.
• In-order to improve effectiveness and reduce antibiotic
prescribing which will also help in reducing drug-drug
interactions, errors and allergic reactions and adverse
drug reactions associated with the unethical use of
antibiotics.
50
GUIDELINES FOR RATIONAL USE OF
ANTIBIOTICS
➢ Use antibiotics only when indicated.
➢ Where appropriate, specimen for gram stain, culture and
sensitivity testing should be obtained before commencing
antibiotic therapy
➢ Choice of agent based on causative organism, safety,
previous clinical response, cost, ease of use and potential.
➢ Adequate dose and duration of treatment is essential.
➢ History of allergy or other ADR should be considered.
51
52
53
54
THANK YOU .....

More Related Content

What's hot

Antibiotics Resistance
Antibiotics ResistanceAntibiotics Resistance
Antibiotics Resistance
Alaa Fadhel Hassan Alwazni
 
Antibiotics resistance lecture
Antibiotics resistance lectureAntibiotics resistance lecture
Antibiotics resistance lecture
Fadel Muhammad Garishah
 
Antibiotic resistance
Antibiotic resistance Antibiotic resistance
Antibiotic resistance
Shavindu Piyadasa
 
Antibiotic resistance mechanism
Antibiotic resistance mechanism Antibiotic resistance mechanism
Antibiotic resistance mechanism
MEHEDI HASAN
 
Bacterial resistance against antibiotics and it’s prevention
Bacterial resistance against antibiotics and it’s preventionBacterial resistance against antibiotics and it’s prevention
Bacterial resistance against antibiotics and it’s preventionWtar Dargalayi
 
0VERVIEW OF ANTIBIOTIC RESISTANCE 111.pptx
0VERVIEW OF ANTIBIOTIC RESISTANCE 111.pptx0VERVIEW OF ANTIBIOTIC RESISTANCE 111.pptx
0VERVIEW OF ANTIBIOTIC RESISTANCE 111.pptx
KrishnaSupalkar
 
Antimicrobial drug resistance
Antimicrobial drug resistanceAntimicrobial drug resistance
Antimicrobial drug resistance
Manas Nath
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
Mrunal Dhole
 
Presentation on antimicrobial resistance
Presentation on antimicrobial resistancePresentation on antimicrobial resistance
Presentation on antimicrobial resistance
Matthew Frimpong Antwi
 
Antibiotic resistance I Mechanism I Types I Contributing factors.
Antibiotic resistance I Mechanism I Types I Contributing factors.Antibiotic resistance I Mechanism I Types I Contributing factors.
Antibiotic resistance I Mechanism I Types I Contributing factors.
kausarneha
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
Sulav Shrestha
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Larry Mweetwa
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
Stanley Palma
 
Diagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policyDiagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policy
Society for Microbiology and Infection care
 
Laboratory detection of resistant bacteria
Laboratory detection of resistant bacteriaLaboratory detection of resistant bacteria
Laboratory detection of resistant bacteria
Mostafa Mahmoud
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
MumtahinaZaman1
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
Dr Vinay Gupta
 
Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance-
 
Misuse of-antibiotics
Misuse of-antibioticsMisuse of-antibiotics
Misuse of-antibiotics
Ali Al Samawy
 
antibiotic resistance whats new???
antibiotic resistance  whats new???antibiotic resistance  whats new???
antibiotic resistance whats new???
Dr. Md Ashraf Ali Namaji
 

What's hot (20)

Antibiotics Resistance
Antibiotics ResistanceAntibiotics Resistance
Antibiotics Resistance
 
Antibiotics resistance lecture
Antibiotics resistance lectureAntibiotics resistance lecture
Antibiotics resistance lecture
 
Antibiotic resistance
Antibiotic resistance Antibiotic resistance
Antibiotic resistance
 
Antibiotic resistance mechanism
Antibiotic resistance mechanism Antibiotic resistance mechanism
Antibiotic resistance mechanism
 
Bacterial resistance against antibiotics and it’s prevention
Bacterial resistance against antibiotics and it’s preventionBacterial resistance against antibiotics and it’s prevention
Bacterial resistance against antibiotics and it’s prevention
 
0VERVIEW OF ANTIBIOTIC RESISTANCE 111.pptx
0VERVIEW OF ANTIBIOTIC RESISTANCE 111.pptx0VERVIEW OF ANTIBIOTIC RESISTANCE 111.pptx
0VERVIEW OF ANTIBIOTIC RESISTANCE 111.pptx
 
Antimicrobial drug resistance
Antimicrobial drug resistanceAntimicrobial drug resistance
Antimicrobial drug resistance
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
Presentation on antimicrobial resistance
Presentation on antimicrobial resistancePresentation on antimicrobial resistance
Presentation on antimicrobial resistance
 
Antibiotic resistance I Mechanism I Types I Contributing factors.
Antibiotic resistance I Mechanism I Types I Contributing factors.Antibiotic resistance I Mechanism I Types I Contributing factors.
Antibiotic resistance I Mechanism I Types I Contributing factors.
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
Diagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policyDiagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policy
 
Laboratory detection of resistant bacteria
Laboratory detection of resistant bacteriaLaboratory detection of resistant bacteria
Laboratory detection of resistant bacteria
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
 
Misuse of-antibiotics
Misuse of-antibioticsMisuse of-antibiotics
Misuse of-antibiotics
 
antibiotic resistance whats new???
antibiotic resistance  whats new???antibiotic resistance  whats new???
antibiotic resistance whats new???
 

Similar to Antibiotic resistance

ANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCEANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCE
Kushal Saha
 
Role of pharmacists in combating drug resistatnce by neel ratnam.
Role of pharmacists in combating drug resistatnce by neel ratnam.Role of pharmacists in combating drug resistatnce by neel ratnam.
Role of pharmacists in combating drug resistatnce by neel ratnam.
neel ratnam
 
IV-chemotherapy ..pharmacy.power point text
IV-chemotherapy ..pharmacy.power point textIV-chemotherapy ..pharmacy.power point text
IV-chemotherapy ..pharmacy.power point text
NathanDanielgashahun
 
antibiotic resistance- Copy (1).pptx
antibiotic resistance- Copy (1).pptxantibiotic resistance- Copy (1).pptx
antibiotic resistance- Copy (1).pptx
AhmedSamir462624
 
Multi drug resistance molecular pathogenesis
Multi drug resistance   molecular pathogenesisMulti drug resistance   molecular pathogenesis
Multi drug resistance molecular pathogenesis
Alagar Suresh
 
Antibiotic Resistance speaker.pptx
Antibiotic Resistance speaker.pptxAntibiotic Resistance speaker.pptx
Antibiotic Resistance speaker.pptx
TanvirIslam187744
 
Neonatal pharm 3 .ppt
Neonatal pharm 3 .pptNeonatal pharm 3 .ppt
Neonatal pharm 3 .ppt
MesfinShifara
 
Antibiotic resistance and suceptibility.
Antibiotic resistance and suceptibility.Antibiotic resistance and suceptibility.
Antibiotic resistance and suceptibility.
MariamShafique5
 
ANTIMICROBIAL DRUGS (Part 2)
ANTIMICROBIAL DRUGS (Part 2) ANTIMICROBIAL DRUGS (Part 2)
ANTIMICROBIAL DRUGS (Part 2)
Surya Amal
 
Antibiotics in pediatric dentistry
Antibiotics in pediatric dentistryAntibiotics in pediatric dentistry
Antibiotics in pediatric dentistry
Shubham Gupta
 
Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH
AjazAttari1
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Walahassan4
 
Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01Mostafa Abd El Fattah
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Mohammed Ezz El-din
 
ANTI MICROBIAL RESISTANCE.pptx for medical students,doctor
ANTI MICROBIAL RESISTANCE.pptx for  medical  students,doctorANTI MICROBIAL RESISTANCE.pptx for  medical  students,doctor
ANTI MICROBIAL RESISTANCE.pptx for medical students,doctor
dipuskmc18
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
Krishna Gandhi
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Krishna Gandhi
 
Antibiotic resistance-MADHURI RUDRARAJU
Antibiotic resistance-MADHURI RUDRARAJUAntibiotic resistance-MADHURI RUDRARAJU
Antibiotic resistance-MADHURI RUDRARAJU
Dr Madhuri Rudraraju
 
Control of Microbial Growth-Antimicrobial Agents
Control of Microbial Growth-Antimicrobial AgentsControl of Microbial Growth-Antimicrobial Agents
Control of Microbial Growth-Antimicrobial Agents
Dr. Samira Fattah
 
Antimicrobial resistance.pptx
Antimicrobial resistance.pptxAntimicrobial resistance.pptx
Antimicrobial resistance.pptx
Dr. Asif Anas
 

Similar to Antibiotic resistance (20)

ANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCEANTIMICROBIAL RESISTANCE
ANTIMICROBIAL RESISTANCE
 
Role of pharmacists in combating drug resistatnce by neel ratnam.
Role of pharmacists in combating drug resistatnce by neel ratnam.Role of pharmacists in combating drug resistatnce by neel ratnam.
Role of pharmacists in combating drug resistatnce by neel ratnam.
 
IV-chemotherapy ..pharmacy.power point text
IV-chemotherapy ..pharmacy.power point textIV-chemotherapy ..pharmacy.power point text
IV-chemotherapy ..pharmacy.power point text
 
antibiotic resistance- Copy (1).pptx
antibiotic resistance- Copy (1).pptxantibiotic resistance- Copy (1).pptx
antibiotic resistance- Copy (1).pptx
 
Multi drug resistance molecular pathogenesis
Multi drug resistance   molecular pathogenesisMulti drug resistance   molecular pathogenesis
Multi drug resistance molecular pathogenesis
 
Antibiotic Resistance speaker.pptx
Antibiotic Resistance speaker.pptxAntibiotic Resistance speaker.pptx
Antibiotic Resistance speaker.pptx
 
Neonatal pharm 3 .ppt
Neonatal pharm 3 .pptNeonatal pharm 3 .ppt
Neonatal pharm 3 .ppt
 
Antibiotic resistance and suceptibility.
Antibiotic resistance and suceptibility.Antibiotic resistance and suceptibility.
Antibiotic resistance and suceptibility.
 
ANTIMICROBIAL DRUGS (Part 2)
ANTIMICROBIAL DRUGS (Part 2) ANTIMICROBIAL DRUGS (Part 2)
ANTIMICROBIAL DRUGS (Part 2)
 
Antibiotics in pediatric dentistry
Antibiotics in pediatric dentistryAntibiotics in pediatric dentistry
Antibiotics in pediatric dentistry
 
Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
ANTI MICROBIAL RESISTANCE.pptx for medical students,doctor
ANTI MICROBIAL RESISTANCE.pptx for  medical  students,doctorANTI MICROBIAL RESISTANCE.pptx for  medical  students,doctor
ANTI MICROBIAL RESISTANCE.pptx for medical students,doctor
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibiotic resistance-MADHURI RUDRARAJU
Antibiotic resistance-MADHURI RUDRARAJUAntibiotic resistance-MADHURI RUDRARAJU
Antibiotic resistance-MADHURI RUDRARAJU
 
Control of Microbial Growth-Antimicrobial Agents
Control of Microbial Growth-Antimicrobial AgentsControl of Microbial Growth-Antimicrobial Agents
Control of Microbial Growth-Antimicrobial Agents
 
Antimicrobial resistance.pptx
Antimicrobial resistance.pptxAntimicrobial resistance.pptx
Antimicrobial resistance.pptx
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 

Recently uploaded (20)

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 

Antibiotic resistance

  • 1. 1
  • 2. PROBLEM OF ANTIBIOTIC RESISTANCE & RATIONAL USE OF ANTIBIOTICS SUHAIL K Lecturer Crescent college of pharmaceutical sciences suhailk4@gmail.com 2
  • 3. INTRODUCTION Throughout history there has been a continual battle between human beings and multitude of micro-organisms that cause infection and disease. ANTIBIOTICS: Produced by micro organism, which selectively suppress the growth of or kill other micro organisms at very low concentrations. 3
  • 4. PROBLEMS WITH USE OF AMAs 1. Toxicity: Local irritancy Systemic toxicity 2. Hypersensitivity reactions 3. Superinfection 4. Nutritional deficiencies 5. Masking of an infection 6. Drug resistance 4
  • 5. Drug resistance occurs in : Bacteria—Antibiotic Resistance Endoparasites Viruses—Resistance to antiviral drugs Fungi Cancer cells 5
  • 6. In his 1945 Nobel Prize lecture, Fleming himself warned of the danger of resistance – “It is not difficult to make microbes resistant to penicillin in the laboratory by exposing them to concentrations not sufficient to kill them, and the same thing has occasionally happened in the body……and by exposing his microbes to non-lethal quantities of the drug make them resistant.” 6
  • 7. Why resistance is a concern: •Resistant organisms lead to treatment failure •Increased mortality •Resistant bacteria may spread in Community •Low level resistance can go undetected •Added burden on healthcare costs •Threatens to return to pre-antibiotic era •Selection pressure 7
  • 8. Antibiotic Resistance The concentration of drug at the site of infection must inhibit the organism and also remain below the level that is toxic to human cells. Defined as micro-organisms that are not inhibited by usually achievable systemic concentration of an antimicrobial agent with normal dosage schedule and / or fall in the minimum inhibitory concentration (MIC) range. 8
  • 9. 9
  • 10. 10
  • 11. Antibiotic Resistance Some microorganisms may ‘born’ resistant, some ‘achieve’ resistance by mutation or some have resistance ‘thrust upon them’ by plasmids Some are born great, some achieve greatness or some have greatness thrust upon them. 11
  • 12. Intrinsic Resistance It occurs naturally. 1. Lack target : • No cell wall; innately resistant to penicillin 2. Innate efflux pumps: • Drug blocked from entering cell or ↑ export of drug (does not achieve adequate internal concentration). Eg. E. coli, P. aeruginosa 3. Drug inactivation: • Cephalosporinase in Klebsiella 12
  • 13. Acquired resistance Mutations • It refers to the change in DNA structure of the gene. • Occurs at a frequency of one per ten million cells. • Eg.Mycobacterium tuberculosis,Mycobacterium lepra , MRSA. • Often mutants have reduced susceptibility 13
  • 14. Plasmids • Extra chromosomal genetic elements can replicate independently and freely in cytoplasm. • Plasmids which carry genes resistant ( r-genes) are called R plasmids. • These r-genes can be readily transferred from one R- plasmid to another plasmid or to chromosome. • Much of the drug resistance encountered in clinical practice is plasmid mediated 14
  • 15. 15
  • 16. Biochemical mechanisms of antibiotic resistance • Prevention of drug accumulation in the bacterium • Modification/protection of the target site • Use of alternative pathways for metabolic / growth requirements • By producing an enzyme that inactivates the antibiotic • Quorum sensing 16
  • 17. Decreased permeability: Porin Loss Antibiotics normally enter bacterial cells via porin channels in the cell wall New porin channels in the bacterial cell wall do not allow antibiotics to enter the cells 17
  • 18. 18
  • 19. 19
  • 20. Structurally modified antibiotic target site Antibiotics normally bind to specific binding proteins on the bacterial cell surface Antibiotics are no longer able to bind to modified binding proteins on the bacterial cell surface 20
  • 21. Modification/Protection of the Target site Target sites Resistant Antibiotics Ribosomal point mutation eg.: Tetracyclines,Macrolides, Clindamycin Altered DNA gyrase. Eg: Fluoroquinolones Modified penicillin binding proteins (Strepto.pneumonia) Eg: Penicillins Mutation in DNA dependant RNA polymerase (M.tuberculosis) Eg: Rifampicin 21
  • 22. Antibiotic inactivation Inactivating enzymes target antibiotics Enzymes bind to antibiotic molecules and destroy or prevent binding to target sites 22
  • 23. a)Inactivation of b-lactam antibiotics •S. aureus, N. gonorrohoea, H.influenza, Produce blactamase which cleaves -lactam ring b)Inactivation of Chloramphenicol • Inactivated by chloramphenicol acetyltransferase . • Gram-ve (enzyme present constitutively hence higher resistance) gram +ve bacteria (enzyme is inducible ) c)Inactivation of Aminoglycosides • Inactivated by acetyl, phospho & adenylyl transferases Present in gram +ve and gram –ve . 23
  • 24. 24
  • 25. Use of alternative pathways for metabolic / growth requirements • Resistance can also occur by alternate pathway that bypasses the reaction inhibited by the antibiotic. • Sulfonamide resistance can occur from over production of PABA 25
  • 26. Quorum sensing • Microbes communicate with each other and exchange signaling chemicals (Autoinducers) • These autoinducers allow bacterial population to coordinate gene expression for virulence, conjugation, apoptosis, mobility and Resistance. • Single autoinducer from single microbe is incapable of inducing any such change • But when its colony reaches a critical density (quorum), threshold of autoinduction is reached and gene 26
  • 27. WHY INHIBIT QUORUM SENSING Proved to be very potent method for bacterial virulence inhibition. Several QS inhibitors molecules has been synthesized which include AHL, AIP, and AI-2 analogues QS inhibitors have been synthesized and have been isolated from several natural extracts such as garlic extract. 27
  • 29. Environmental Factors Huge populations and overcrowding • Rapid spread by better transport facility • Poor sanitation • Increases community acquired resistance • Ineffective infection control program • Widespread use of antibiotics in animal husbandry and agriculture and as medicated cleansing products 29
  • 30. Drug Related Factors • Over the counter availability of antimicrobials • Counterfeit and substandard drug causing suboptimal blood concentration • Irrational fixed dose combination of antimicrobials • Soaring use of antibiotics 30
  • 31. Patient Related Factors • Poor adherence of dosage Regimens • Poverty • Lack of sanitation concept • Lack of education • Self-medication • Misconception 31
  • 32. Prescriber Related Factors • Inappropriate use of available drugs • Increased empiric poly-antimicrobial use • Over use of antimicrobials • Inadequate dosing • Lack of current knowledge and training 32
  • 33. Strategy to Contain Resistance • Develop new antibiotics – Bypass the drug resistance • Judicious use of the existing antibiotics: – Containment of drug resistance 33
  • 34. • Only 15 antibiotics of 167 under development had a new mechanism of action with the potential to combat of multidrug resistance. • Lack of incentive for companies to develop antibiotics. 34
  • 35. 35
  • 36. Hope is not exhausted….yet Phage therapy • Use of the lytic enzymes found in mucus and saliva • Agents that target type IIA topoisomerases • Antimicrobial peptides (AMPs), lipopeptides (AMLPs) target bacterial membranes, making it nearly impossible to develop resistance (bacteria would have to totally change their membrane composition). 36
  • 37. Phage therapy • Phage Therapy is the therapeutic use of lytic bacteriophages to treat pathogenic bacteria infections • Bacteriophages are viruses that invade bacterial cells and disrupt bacterial metabolism. • The success rate was 80–95% • British studies also demonstrated significant efficacy of phages against Escherichia coli, Acinetobacter sp, Pseudomonas sp and Staphylococcus aureus. 37
  • 38. Prevention and control Antibiotic resistance is accelerated by the misuse and overuse of antibiotics, as well as poor infection prevention and control. Steps can be taken at all levels of society to reduce the impact and limit the spread of resistance. 38
  • 39. 39 Individuals • Only use antibiotics when prescribed • Never demand antibiotics if your health worker says you don’t need them. • Always follow your health worker’s advice when using antibiotics. • Never share or use leftover antibiotics.
  • 40. 40 • Prevent infections by regularly washing hands, preparing food hygienically, avoiding close contact with sick people, practicing safer sex, and keeping vaccinations up to date. • Prepare food hygienically, following the WHO Five Keys to Safer Food (keep clean, separate raw and cooked, cook thoroughly, keep food at safe temperatures, use safe water and raw materials) and choose foods that have been produced without the use of antibiotics for growth promotion or disease prevention in healthy animals.
  • 41. Poor Clinical Practice Poor clinical practice that fail to incorporate the pharmacological properties of antimicrobials amplify the speed of development of drug resistance 41
  • 42. Faulty Antibiotic Use • Antimicrobials are over prescribed • Available without prescription • Clinician should first determine whether antimicrobial therapy is warranted for a given patient 42
  • 43. Empirical Microbial Selection • Is antimicrobial agents indicated on the basis of clinical findings? • Or is it prudent to wait until such clinical findings become apparent? •Can some simple bed side test done to confirm your suspicion? – Microscopy – Gram staining Have appropriate clinical specimens been obtained to 43
  • 44. • What are the likely etiologic agents for the patient’s illness? • Is there clinical evidence (e.g. from clinical trials) that antimicrobial therapy will confer clinical benefit for the patient? (Evidence-based medicine) 44
  • 45. Definitive Treatment • Can a narrower spectrum agent be substituted for initial empiric drug? • Is one agent or combination of agents necessary? • What are the – optimum dose, – route of administration and – duration of therapy? • What specific test to identify patients who will not respond to treatment? 45
  • 46. • What adjunctive measures can be undertaken to eradicate infection? – Vaccination – Steroid – Drainage of pus – Amputation – Removal of catheter 46
  • 47. Microbiologist Bacterial sensitivity test and find out the possible causes of development Physician treatment 47
  • 48. PHARMACOLOGIST Advise the proper and adequate antibiotics with balancing the economy of hospital 48
  • 49. Role of Pharmacist in Combating Resistance: • Promote awareness among the population, for ethical or proper safe use of antibiotics. • Must obtain accreditation and training for disbursement of knowledge about antibiotic. • Helping physicians with drug selection and deciding on duration of therapy, designing and promotion of clinical practice guidelines, implementation of antibiotic switch programmes, and documentation of the effectiveness of interventions. 49
  • 50. • All hospitals should have an antibiotic pharmacist who has the rights to interfere in the treatment which are associated with antibiotics in the prescription. • In-order to improve effectiveness and reduce antibiotic prescribing which will also help in reducing drug-drug interactions, errors and allergic reactions and adverse drug reactions associated with the unethical use of antibiotics. 50
  • 51. GUIDELINES FOR RATIONAL USE OF ANTIBIOTICS ➢ Use antibiotics only when indicated. ➢ Where appropriate, specimen for gram stain, culture and sensitivity testing should be obtained before commencing antibiotic therapy ➢ Choice of agent based on causative organism, safety, previous clinical response, cost, ease of use and potential. ➢ Adequate dose and duration of treatment is essential. ➢ History of allergy or other ADR should be considered. 51
  • 52. 52
  • 53. 53

Editor's Notes

  1. Resistance resulting from altered target sites
  2. Patient Counseling, Awareness Program
  3. Bacteriophage therapy is an important alternative to antibiotics